Table 1.
Ref.
|
Year
|
Paraneoplastic syndrome
|
Mediator
|
Dermatologic | |||
Ravnborg et al[15] | 1993 | Acanthosis nigricans | TGF-alpha |
Suchonwanit et al[19] | 2018 | Alopecia | T-lymphocytes |
Antoniou et al[20] | 2012 | Alopecia | T-lymphocytes |
Suh et al[23] | 2016 | Dermatomyositis | |
Yasuda et al[26] | 2018 | Dermatomyositis | |
Sotoodian et al[27] | 2018 | Disseminated superficial porokeratosis | p53 |
Cannavó et al[29] | 2008 | Disseminated superficial porokeratosis | p53 |
Chiyomaru et al[33] | 2010 | Necrolytic migratory erythema | |
Tzovaras et al[36] | 2007 | Persistent erythema multiforme | |
Shinojima et al[39] | 2006 | Sweet syndrome | G-CSF, IL-1, IL-6 |
Karabulut et al[43] | 2006 | Bazex syndrome | |
Liau et al[47] | 2016 | Erythema gyratum | |
Bar-Ilan et al[48] | 2017 | Pityriasis rubra pilaris | |
Morgenthau et al[51] | 2019 | Sign of leser- trelat | EGF-alpha |
Opneja et al[53] | 2015 | Subacute cutaneous lupus erythematosus |
TGF-alpha: Tissue growth factor-alpha; G-CSF: Granulocyte-colony stimulating factor; IL: Interleukin; EGF-alpha: Epidermal growth factor-alpha.